ClotHunter™ paired with ZelanteDVT™ Thrombectomy Catheter Enhancement
The first and only tool of its kind, ClotHunter's unique design directs the inflow window of ZelanteDVT to target acute and sub-acute clots with greater circumferential rotation.
Learn more about ClotHunter:
https://www.bostonscientific.com/en-US/products/thrombectomy-systems/angiojet-thrombectomy-system/Venous.html
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
PI 948203 AA
Видео ClotHunter™ paired with ZelanteDVT™ Thrombectomy Catheter Enhancement канала Boston Scientific Peripheral Vascular
Learn more about ClotHunter:
https://www.bostonscientific.com/en-US/products/thrombectomy-systems/angiojet-thrombectomy-system/Venous.html
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
PI 948203 AA
Видео ClotHunter™ paired with ZelanteDVT™ Thrombectomy Catheter Enhancement канала Boston Scientific Peripheral Vascular
Показать
Комментарии отсутствуют
Информация о видео
30 марта 2021 г. 3:24:42
00:02:10
Другие видео канала
![See How the Microfoam is Generated](https://i.ytimg.com/vi/t1Q8e3_7jG0/default.jpg)
![Eluvia™ Drug-Eluting Vascular Stent Part 4: The Heritage](https://i.ytimg.com/vi/EDPVhvuhFSw/default.jpg)
![Treatment of CLI Patient with SFA CTO and Non-Healing Ulcer](https://i.ytimg.com/vi/MDTrOROjCIA/default.jpg)
![Varithena's Impact on Venous Leg Ulcers](https://i.ytimg.com/vi/z9Zke0bs3zw/default.jpg)
![EKOS™ Control Unit 4.0 Animation](https://i.ytimg.com/vi/WbraTiYZcoM/default.jpg)
![Eluvia™ Drug-Eluting Vascular Stent Part 2: The Data](https://i.ytimg.com/vi/pk-WqH3Wo-A/default.jpg)
![Eluvia™ Drug-Eluting Vascular Stent Part 1: The Breakthrough](https://i.ytimg.com/vi/8ckw4CWRmu8/default.jpg)
![Eluvia™ Drug-Eluting Vascular Stent: The Solution](https://i.ytimg.com/vi/JbeBwPqVm1o/default.jpg)
![Varithena (polidocanol injectable foam) 1% Clinical Studies Animation](https://i.ytimg.com/vi/8EQRAscWG6c/default.jpg)
![EKOS™ Endovascular System: The ULTIMA Trial Results](https://i.ytimg.com/vi/0lN0MtbY1xU/default.jpg)
![AVLS 2022 Varithena® Symposium](https://i.ytimg.com/vi/oc_O7-qvrmE/default.jpg)
![Eluvia™ Drug-Eluting Vascular Stent Part 3: The Challenge](https://i.ytimg.com/vi/o0aScWkwi_A/default.jpg)
![Varithena Mechanism of Action](https://i.ytimg.com/vi/riG0DLFfUM8/default.jpg)
![Strategies for real world use of Varithena](https://i.ytimg.com/vi/fcnyI1mDgGA/default.jpg)
![Thrombotic Lesion in Popliteal Artery and Tibial Vessels](https://i.ytimg.com/vi/VEw0aIj6-Ew/default.jpg)
![The Design of the Innova Stent System](https://i.ytimg.com/vi/cEADQPyYTHY/default.jpg)
![Drug Eluting Portfolio Video](https://i.ytimg.com/vi/OJpF1Ziz2ec/default.jpg)
![The Making of Eluvia](https://i.ytimg.com/vi/l3vH-73GcDY/default.jpg)
![Varithena Mechanism of Action](https://i.ytimg.com/vi/4gMZmYk4_dk/default.jpg)
![EKOS+ Endovascular System: How it Works](https://i.ytimg.com/vi/AWH4XfqbZ1c/default.jpg)